PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH BREAST CANCER ASSISTED AT HOSPITAL DAS CLÍNICAS OF GOIÁS
VAZ-GONÇALVES, L. (Universidade Federal de Goiás), SCHINCAGLIA, R.M. (Universidade Federal de Goiás), MARTINS, K.A. (Universidade Federal de Goiás), VILELLA, P.R. (Universidade Federal de Goiás), SIQUEIRA, J.M. (Universidade Federal de Goiás), CORREIA, E.
PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH BREAST CANCER ASSISTED AT HOSPITAL DAS CLÍNICAS OF GOIÁS
VAZ-GONÇALVES, L. (Universidade Federal de Goiás), SCHINCAGLIA, R.M. (Universidade Federal de Goiás), MARTINS, K.A. (Universidade Federal de Goiás), VILELLA, P.R. (Universidade Federal de Goiás), SIQUEIRA, J.M. (Universidade Federal de Goiás), CORREIA, E.
Universidade Federal de GoiásThe objective was to verify the prevalence of Metabolic Syndrome (MS) according to NCEP/ATP III AUC in patients with breast cancer. Cross-sectional study of 62 women with breast cancer treated at the Mastology Program of Hospital das Clínicas de Goiás. For the MS evaluation, in accordance with NCEP/ATP III AUC, among the criteria of waist circumference (WC)> 88cm, triglycerides (TG)> 150mg / DL, HDL cholesterol < 50mg / dL, systolic and / or diastolic blood pressure ≥ 130 and ≥ 85mmHg, respectively (or diagnosis of hypertension) and fasting glycemia ≥110mg / dL (or a diagnosis of diabetes), at least three of them were necessary to be positive for diagnoses of MS. Among the alternative methods, it is worth highlighting its isolated use or associated, such as Visceral Adiposity Index (VAI: WC, TG and HDL) – isolated and other associates, considering different scores (3, 2 and 1), are: Lipid accumulation product (LAP: WC and TG), Conicity index (CI: WC), Waist-to-height ratio (WHtR: WC) and body fat percentage (%FC: WC). About the participants, 72.6% were adults, 69.4% self-reported black/brown and 53.2% lived with their partners, 59.7% hypertensive, 19.9% diabetic, 14.5% were altered fasting glycemia and 79.0 % dyslipidemic. Regarding to methods, it was found increased values for VAI (50,0%); LAP (19,4%); IC (93,6%); WHtR (82,3%) e %FG (77,4%). Concerning to prevalence, it was found 40,3% obtained by the standard method of diagnoses, WHtR e %FG (associated); 50,0% VAI (isolated); 41,9% (IC) and 17,7% (LAP), associated. It was concluded that use of the method WHtR; %FG and IC (associated) did not compromise the diagnosis of MS when compared to standard criteria and the use VAI overestimates the results. On the other hand, the results obtained by LAP underestimates the MS diagnoses. In this way, alternative methods of easy execution and low costs can be used, considering the association of risk factors between the MS and the breast cancer.adipose tissue, breast cancer, cardiovascular diseases